CellType Launches CT-Translate, a Preclinical-to-Clinical Foundation Model for Patient Response

david_van_dijk · x · 2026-10-21

CellType introduced CT-Translate, a preclinical-to-clinical foundation model built to predict patient outcomes from lab data — a long-sought goal in drug development. In its top-ranked third of immunotherapy patients, 61% responded versus 43% overall, according to the company. The model joins preclinical and patient data to answer how a patient will respond to treatment.

Original post →

More from Apps

Apps channel →